Hypertension: Joint national committee on detection, evaluation, and treatment of high blood pressure guidelines

Current Opinion in Neurology

Volumn 26, Issue 1, 2013, Pages 8-12

  Lackland, Daniel T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

hypertension guidelines; implementation; stroke

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIASTOLIC BLOOD PRESSURE; EVIDENCE BASED PRACTICE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PUBLIC HEALTH; REVIEW; RISK REDUCTION; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; EVIDENCE-BASED PRACTICE; GUIDELINES AS TOPIC; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; STROKE;

EID: 84872957370     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32835c4f54     Document Type: Review

References (41)

1. Society of Actuaries: build and blood pressure study. Vol. 1. Chicago, IL: Society of Actuaries; 1959.
2. Freis ED. The role of hypertension. Am J Hypertens 1960; 50:11-13.
3. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks.USpopulation data. Arch Intern Med 1993; 153:598-615.
4. Flack JM, Neaton J, Grimm R Jr, et al. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation 1995; 92:2437-2445.
5. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
6. Kuller LH. Epidemiology and prevention of stroke, now and in the future. Epidemiol Rev 2000; 22:14-17.
7. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
8. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
9. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva, Switzerland. Available at http://www.who.int/ whr/2002/. [Accessed 23 July 2012].
10. Roccella EJ. The National High Blood Pressure Education Program. In: Oparil S, Weber M, editors. Hypertension: a companion to Brenner and Rector's the kidney. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2005.
11. Wright JD, Hughes JP, Ostchega Y. Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008. National Health Statistics Reports; no. 35. Hyattsville, MD: National Center for Health Statistics; 2011. This is the most recent NHANES SBP data.
12. Yoon SS, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS Data Brief, no. 48. Hyattsville, MD: National Center for Health Statistics; 2010.
13. Franklin SS, Gustin WT, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96:308-315.
14. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002; 287:1003-1010.
15. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's Strategic Impact Goal through 2020 and beyond. Circulation 2010; 121:586-613.
16. Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency ofprogression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682-1686.
17. Lackland DT, Keil JE, Gazes PC, et al. Outcomes of black and white hypertensive individuals after 30 years of follow-up. Clin Exp Hypertens 1995; 17:1091-1105.
18. Gazes PC, Lackland DT, Mountford WK, et al. Comparison of cardiovascular risk factors for high brachial pulse pressure in blacks versus whites (Charleston Heart Study, Evans County Study, NHANES I and II Studies). Am J Cardiol 2008; 102:1514-1517.
19. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000; 35:539-543.
20. Lackland DT, Egan BM, Mountford WK, et al. Thirty-year survival for black and white hypertensive individuals in the Evans County Heart Study and the hypertension detection and follow-up program. J Am Soc Hypertens 2008; 2:448-454.
21. He J, Whelton PF. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138:S211-S219.
22. Report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. A cooperative study. JAMA 1977; 237:255-261.
23. The 1980 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1980; 140:1280-1285.
24. The 1988 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med1988; 148:1023-1038.
25. The 1984 report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1984; 144:1045-1057.
26. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153:154-183.
27. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
28. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
29. Handler J, Lackland DT. Translation of hypertension treatment guidelines into practice: a review of implementation.J Am Soc Hypertens 2011; 5:197-207.
30. Bertoia ML, Waring ME, Gupta PS, et al. Implications of new hypertension guidelines in the United States. Hypertension 2012; 60:639-644.
31. Lackland DT, Elkind MS, D'Agostino R Sr, et al. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare profes sionals from the American Heart Association/American Stroke Association. Stroke 2012; 43:1998-2027.
32. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:227-276.
33. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
34. Yusuf S, Diener HC, Sacco RL, et al., for the PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008; 359:1225-1237.
35. The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367:817-825.
36. Graham R, Mancher M, Wolman DM, et al., editors. Clinical practice guidelines we can trust. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine; 2011
37. Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical guidelines. JAMA 2009; 301:831-841.
38. Fryar CD, Chen T, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010. NCHS data brief. no. 103. Hyattsville, MD: National Center for Health Statistics; 2012. This study is the more recent data from NHANES and described the public health burden of uncontrolled hypertension in the United States. CDC.
39. Centers for Disease Control and Prevention. Million hearts: strategies to reduce the prevalence of leading disease risk factors-United States, 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1248-1251.
40. Tomaselli GF, Harty MB, Horton K, Schoeberl M. The American Heart Association and the Million Hearts Initiative: a presidential advisory from the American Heart Association. Circulation 2011; 124:1795-1799.
41. Sacco RL, Frieden TR, Blakeman DE, et al. What the million heart initiative means for stroke. A presidential advisory from the American Heart Associa tion/American Stroke Association. Stroke 2012; 43:924-928.